Skip to content
CharitiesAidWelfare, Medical Health Aged Care

Bowel cancer screening rates stagnate

Bowel Cancer Australia 2 mins read

EMBARGOED UNTIL 4AM Thursday, 13 June 2024, Sydney: According to the latest AIHW National Bowel Cancer Screening Program (NBCSP) Monitoring Report 2024[i], there was a further decline in Program participation to 40% (2021: 40.9%).

 

6 million Australians aged 50-74 were invited to participate in the Program, yet 6-in-10 did not return their free bowel cancer screening test, despite several multi-million-dollar National Bowel Cancer Screening Program advertising campaigns to increase Program participation.

 

Bowel Cancer Australia CEO, Julien Wiggins said, “This is the second consecutive year of declining NBCSP participation rates since 2020, which is of concern, given the Program’s life-saving potential as 99% of bowel cancer cases can be successfully treated when detected early.

 

In 2022, 64,932 (5.7%) participants received a positive result, meaning blood was detected in the poo sample that is non-visible to the naked eye and required further investigation via colonoscopy.

 

However, only 13.5% were recorded as having received a colonoscopy within the recommended 30-day timeframe, down from 15.6% in 2021. Participants waited between 133 days and 197 days, depending on where they lived (2021: 119-235 days).

 

 “The opportunity for early detection is lost if a positive screening result is not promptly followed by a colonoscopy,” Mr Wiggins added.

 

Bowel Cancer Australia also welcomed another milestone in its 6-year campaign, with the eligible screening age for the NBCSP being lowered from 50 to 45.

 

From 1 July 2024 eligible people aged 45-49 can opt-in and request their first bowel cancer screening test be mailed to them. The next test will automatically be mailed every 2 years after their last screening test is completed.

 

Each year over 15,300 Australians are diagnosed with bowel cancer, with 1 in 9 new bowel cancer cases occurring in people under age 50.

 

Bowel cancer is Australia’s second deadliest cancer, claiming over 5,300 lives each year.

 

--- ENDS ---

 

June is Bowel Cancer Awareness Month – Bowel Cancer Australia’s signature event to raise awareness of Australia’s second deadliest cancer and funds for the leading community-funded charity dedicated to championing what matters most to people impacted by bowel cancer and empowering everyone affected to live their best life.

 

For more information visit – bowelcanceraustralia.org or call 1800 727 336 (SCREEN).

 

NBCSP participation rate (%) of people aged 50-74, Australia, 2008-09 to 2021-22i

 

2008-09

2009-10

2010-11

2011-12

2012-13

2013-14

2014-15

2015-16

2016-17

2017-18

2018-19

2019-20

2020-21

2021-22

43.6

41.0

38.6

37.0

36.1

37.4

38.9

40.9

41.3

42.4

43.5

43.8

40.9

40.0

 

 

NBCSP participation rate (%) of people aged 50-74, by state and territory

 

 

Participation rate %
2022

Participation rate %
2021

NSW

38.7 ¯

39.5

VIC

42.6 ¯

43.9

QLD

36.9 ¯

37.5

WA

40.5 ¯

41.5

SA

44.1 ¯

44.4

TAS

43.8 ¯

44.4

ACT

43.9 ¯

44.0

NT

27.4 ­

25.6

Australia

40.0 ¯

40.9

 

Time between positive screen & diagnostic assessment, people aged 50-74, by state and territory (days)

 

 

90th percentile

2022

90th percentile

2021

NSW

160 ¯

162

VIC

150 ­

136

QLD

153 ­

141

WA

133 ­

119

SA

160 ­

154

TAS

197 ¯

235

ACT

159 ­

151

NT

175 ¯

178

Australia

155 ­

147



[i] Australian Institute of Health and Welfare (2024) National bowel cancer screening program monitoring report 2024, catalogue number CAN 160, AIHW, Australian Government.


Contact details:


For an interview with a medical expert or patient contact:
Stephanie Bansemer-Brown – Bowel Cancer Australia
[email protected]   |   0412 915 797

Media

More from this category

  • Medical Health Aged Care
  • 12/12/2025
  • 10:11
Cosette Pharmaceuticals, Inc.

Termination of Proposed Acquisition of Mayne Pharma

BRIDGEWATER, N.J.–BUSINESS WIRE– Cosette Pharmaceuticals, Inc. (Cosette), a U.S.-based, fully integrated pharmaceutical company, confirms that on 9 December 2025 it served a notice on…

  • Contains:
  • Medical Health Aged Care
  • 12/12/2025
  • 08:55
Royal Australian College of GPs

Universal Health Coverage Day: RACGP calls out need for better funding for chronic conditions and preventive care

Specialist GPs have marked International Universal Health Coverage (UHC) Day by joining the World Health Organization in highlighting the devastating impact of health costs. The Royal Australian College of GPs (RACGP) has stressed that a public health system which forces patients with complex or chronic conditions to pay out of pocket for longer consultations can’t claim to offer universal coverage, and urged governments to protect patients from financial hardship. “Health is a human right,” RACGP President Dr Michael Wright said. “Australia recognises the right of everyone to the highest attainable standard of physical and mental health, and our governments are…

  • Contains:
  • Medical Health Aged Care, Women
  • 12/12/2025
  • 01:00
Breast Cancer Trials

Simple blood tests could help tailor treatment for aggressive breast cancer

Key Facts: Blood tests detecting circulating tumour DNA could help guide treatment for triple negative breast cancer patients Absence of tumour DNA in blood…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.